(Q72096298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

reason for preferred rank

23 October 2019

title

D-Arg1, D-Phe5, D-Trp7,9, Leu11substance P inhibits the growth of human small cell lung cancer xenografts in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

22 August 2024

D-Arg1, D-Phe5, D-Trp7,9, Leu11 substance P inhibits the growth of human small cell lung cancer xenografts in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

author name string

M. J. Everard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

V. M. Macaulay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

J. L. Millar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

I. E. Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7691115

22 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7691115

22 August 2024

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 October 2019

https://api.elsevier.com/content/article/PII:095980499390019C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

https://api.elsevier.com/content/article/PII:095980499390019C?httpAccept=text/plain

22 August 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

European Journal of Cancer

22 August 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

29A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

1450-1453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research

23 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

22 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer

22 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?

22 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro

22 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

A peptide that inhibits the mitogenic stimulation of Swiss 3T3 cells by bombesin or vasopressin

22 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin

22 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Bradykinin receptors: characterization, distribution and mechanisms of signal transduction

22 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells

22 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

22 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

cDNA cloning of bovine substance-K receptor through oocyte expression system.

22 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro

22 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth

22 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

22 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

22 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer

22 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

The binding of endogenous and exogenous substance-P in human plasma

22 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Metabolism of protein anticancer agents.

22 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Analgesic effect of antagonists of substance P

22 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

The antagonism of bombesin in the CNS by substance P analogues

22 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Tachykinin antagonists have potent local anaesthetic actions

22 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

Sensory and Motor Functions of Spinal Cord Substance P

22 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/0959-8049(93)90019-C

22 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7691115%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference